{"filing":{"accession_number":"0001193125-26-299132","cik":"0001885827","ticker":"VRAX","company_name":"Virax Biolabs Group Ltd","form":"6-K","filing_date":"2026-07-09","report_date":null,"primary_document":"6-k_7.9.26_fosun.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1885827/000119312526299132/6-k_7.9.26_fosun.htm"},"events":[{"id":16790,"run_id":15019,"accession_number":"0001193125-26-299132","anchor_item_number":"EX-99.1","event_type":"operational_other","event_domain":"operational","is_material":true,"confidence":0.85,"summary":"Virax Biolabs announced an exclusive multi-country commercial supply agreement with Fosun Diagnostics covering six Southeast Asian markets for its ImmuneSelect product line. This is a material strategic partnership and commercial milestone that establishes a framework for immediate product supply and revenue opportunities, representing a significant operational and commercial development for the company's business expansion in the ASEAN region.","company_name":"Virax Biolabs Group Ltd","ticker":"VRAX","filing_date":"2026-07-09","form":"6-K","submitted_at":null,"items":[{"id":14990,"accession_number":"0001193125-26-299132","item_number":"EX-99.1","item_title":"vrax-ex99_1.htm","event_type":"operational_other","event_domain":"operational","is_material":true,"confidence":0.85,"reasoning":"Virax Biolabs announced an exclusive multi-country commercial supply agreement with Fosun Diagnostics covering six Southeast Asian markets for its ImmuneSelect product line. This is a material strategic partnership and commercial milestone that establishes a framework for immediate product supply and revenue opportunities, representing a significant operational and commercial development for the company's business expansion in the ASEAN region.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-07-10T10:29:54.977377+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":14990,"accession_number":"0001193125-26-299132","item_number":"EX-99.1","item_title":"vrax-ex99_1.htm","event_type":"operational_other","event_domain":"operational","is_material":true,"confidence":0.85,"reasoning":"Virax Biolabs announced an exclusive multi-country commercial supply agreement with Fosun Diagnostics covering six Southeast Asian markets for its ImmuneSelect product line. This is a material strategic partnership and commercial milestone that establishes a framework for immediate product supply and revenue opportunities, representing a significant operational and commercial development for the company's business expansion in the ASEAN region.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-07-10T10:29:54.977377+00:00","company_name":"Virax Biolabs Group Ltd","ticker":"VRAX","filing_date":"2026-07-09"}]}